BLUE CAP AG (B7E.DE) Fundamental Analysis & Valuation

FRA:B7E • DE000A0JM2M1

Current stock price

17.8 EUR
+0.05 (+0.28%)
Last:

This B7E.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. B7E.DE Profitability Analysis

1.1 Basic Checks

  • B7E had positive earnings in the past year.
  • B7E had a positive operating cash flow in the past year.
  • Of the past 5 years B7E 4 years were profitable.
  • Each year in the past 5 years B7E had a positive operating cash flow.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • B7E has a better Return On Assets (9.48%) than 88.60% of its industry peers.
  • B7E has a better Return On Equity (20.25%) than 82.46% of its industry peers.
  • With a decent Return On Invested Capital value of 6.33%, B7E is doing good in the industry, outperforming 72.81% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for B7E is below the industry average of 9.36%.
  • The 3 year average ROIC (5.02%) for B7E is below the current ROIC(6.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROIC 6.33%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • The Profit Margin of B7E (11.71%) is comparable to the rest of the industry.
  • B7E's Profit Margin has improved in the last couple of years.
  • B7E's Operating Margin of 8.02% is in line compared to the rest of the industry. B7E outperforms 54.39% of its industry peers.
  • B7E's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 49.70%, B7E is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • B7E's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. B7E.DE Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, B7E has about the same amount of shares outstanding.
  • The number of shares outstanding for B7E has been increased compared to 5 years ago.
  • B7E has a better debt/assets ratio than last year.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 2.19 indicates that B7E is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of B7E (2.19) is better than 72.81% of its industry peers.
  • B7E has a debt to FCF ratio of 4.61. This is a neutral value as B7E would need 4.61 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.61, B7E is in the better half of the industry, outperforming 77.19% of the companies in the same industry.
  • A Debt/Equity ratio of 0.32 indicates that B7E is not too dependend on debt financing.
  • B7E has a better Debt to Equity ratio (0.32) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Altman-Z 2.19
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • B7E has a Current Ratio of 1.73. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.73, B7E is in the better half of the industry, outperforming 76.32% of the companies in the same industry.
  • B7E has a Quick Ratio of 1.39. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of B7E (1.39) is better than 72.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.39
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. B7E.DE Growth Analysis

3.1 Past

  • B7E shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 292.72%, which is quite impressive.
  • The Earnings Per Share has been growing by 33.00% on average over the past years. This is a very strong growth
  • The Revenue has decreased by -0.59% in the past year.
  • B7E shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.79% yearly.
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%

3.2 Future

  • The Earnings Per Share is expected to decrease by -55.87% on average over the next years. This is quite bad
  • Based on estimates for the next years, B7E will show a decrease in Revenue. The Revenue will decrease by -5.75% on average per year.
EPS Next Y13.76%
EPS Next 2Y-88.67%
EPS Next 3Y-55.87%
EPS Next 5YN/A
Revenue Next Year-38.12%
Revenue Next 2Y-20.3%
Revenue Next 3Y-12.42%
Revenue Next 5Y-5.75%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. B7E.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 3.95, which indicates a rather cheap valuation of B7E.
  • Based on the Price/Earnings ratio, B7E is valued cheaper than 96.49% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of B7E to the average of the S&P500 Index (26.91), we can say B7E is valued rather cheaply.
  • The Price/Forward Earnings ratio is 306.50, which means the current valuation is very expensive for B7E.
  • The rest of the industry has a similar Price/Forward Earnings ratio as B7E.
  • B7E's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.68.
Industry RankSector Rank
PE 3.95
Fwd PE 306.5
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • B7E's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. B7E is cheaper than 96.49% of the companies in the same industry.
  • 93.86% of the companies in the same industry are more expensive than B7E, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.74
EV/EBITDA 3
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • B7E's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of B7E may justify a higher PE ratio.
  • B7E's earnings are expected to decrease with -55.87% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.29
PEG (5Y)0.12
EPS Next 2Y-88.67%
EPS Next 3Y-55.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. B7E.DE Dividend Analysis

5.1 Amount

  • B7E has a Yearly Dividend Yield of 3.74%.
  • Compared to an average industry Dividend Yield of 3.35, B7E pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, B7E pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.74%

5.2 History

  • The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • The Dividend Rate of B7E has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-88.67%
EPS Next 3Y-55.87%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

B7E.DE Fundamentals: All Metrics, Ratios and Statistics

BLUE CAP AG

FRA:B7E (4/9/2026, 7:00:00 PM)

17.8

+0.05 (+0.28%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-26
Earnings (Next)05-12
Inst Owners27.6%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap79.92M
Revenue(TTM)174.60M
Net Income(TTM)20.44M
Analysts82.5
Price Target30.55 (71.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.74%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)80.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 3.95
Fwd PE 306.5
P/S 0.46
P/FCF 5.74
P/OCF 3.94
P/B 0.79
P/tB 1.51
EV/EBITDA 3
EPS(TTM)4.51
EY25.34%
EPS(NY)0.06
Fwd EY0.33%
FCF(TTM)3.1
FCFY17.41%
OCF(TTM)4.51
OCFY25.36%
SpS38.89
BVpS22.48
TBVpS11.77
PEG (NY)0.29
PEG (5Y)0.12
Graham Number47.76
Profitability
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROCE 9.09%
ROIC 6.33%
ROICexc 9.23%
ROICexgc 16.8%
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
FCFM 7.97%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexgc growth 3Y54.39%
ROICexgc growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score8
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Debt/EBITDA 1.04
Cap/Depr 37.43%
Cap/Sales 3.64%
Interest Coverage 3.69
Cash Conversion 65.44%
Profit Quality 68.08%
Current Ratio 1.73
Quick Ratio 1.39
Altman-Z 2.19
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
EPS Next Y13.76%
EPS Next 2Y-88.67%
EPS Next 3Y-55.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%
Revenue Next Year-38.12%
Revenue Next 2Y-20.3%
Revenue Next 3Y-12.42%
Revenue Next 5Y-5.75%
EBIT growth 1Y224.21%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-25.67%
EBIT Next 3Y-21.89%
EBIT Next 5Y-14.12%
FCF growth 1Y-38.99%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-27.35%
OCF growth 3Y1.47%
OCF growth 5Y47.8%

BLUE CAP AG / B7E.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLUE CAP AG (B7E.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to B7E.DE.


What is the valuation status of BLUE CAP AG (B7E.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to BLUE CAP AG (B7E.DE). This can be considered as Undervalued.


How profitable is BLUE CAP AG (B7E.DE) stock?

BLUE CAP AG (B7E.DE) has a profitability rating of 7 / 10.


What is the financial health of BLUE CAP AG (B7E.DE) stock?

The financial health rating of BLUE CAP AG (B7E.DE) is 5 / 10.


What is the expected EPS growth for BLUE CAP AG (B7E.DE) stock?

The Earnings per Share (EPS) of BLUE CAP AG (B7E.DE) is expected to grow by 13.76% in the next year.